您的当前位置:首页 > Leisure > 【mated to the alpha and his beta lanie】SHAREHOLDER ALERT: PTLA GERN AAN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines 正文
时间:2024-09-29 12:27:15 来源:网络整理 编辑:Leisure
NEW YORK, NY / ACCESSWIRE / March 4, 2020 /The Law Offices of Vincent Wong announce that class actio mated to the alpha and his beta lanie
NEW YORK,mated to the alpha and his beta lanie NY / ACCESSWIRE / March 4, 2020 /
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
There will be no obligation or cost to you.
Portola Pharmaceuticals, Inc.
(
PTLA
)
If you suffered a loss, contact us at:
http://www.wongesq.com/pslra-1/portola-pharmaceuticals-inc-loss-submission-form?prid=5581&wire=1
Lead Plaintiff Deadline:
March 16, 2020
Class Period: May 8, 2019 to January 9, 2020
Allegations against PTLA include that: (1) Portola's internal control over financial reporting regarding reserve for product returns was not effective; (2) Portola was shipping longer-dated product with 36-month shelf life; (3) Portola had not established adequate reserve for returns of prior shipments of short-dated product; (4) as a result, Portola was reasonably likely to need to "catch up" on accounting for return reserves; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Geron Corporation
(
GERN
)
If you suffered a loss, contact us at:
http://www.wongesq.com/pslra-1/geron-corporation-et-al-loss-submission-form?prid=5581&wire=1
Lead Plaintiff Deadline:
March 23, 2020
Class Period: March 19, 2018 to September 26, 2018
The filed complaint alleges that defendants misled investors regarding a drug called imetelstat, which was intended to treat certain cancers that occur in bone marrow. Specifically, defendants misled investors about the results of a clinical drug study of imetelstat called IMbark. That study was designed to ascertain whether imetelstat helped patients with a cancer called myelofibrosis.
Aarons, Inc.
(
AAN
)
If you suffered a loss, contact us at:
http://www.wongesq.com/pslra-1/aarons-inc-loss-submission-form?prid=5581&wire=1
Lead Plaintiff Deadline:
April 28, 2020
Class Period: March 2, 2018 to February 19, 2020
Allegations against AAN include that: (i) Aaron's had inadequate disclosure controls, procedures, and compliance measures; (ii) consequently, the operations of Aaron's Progressive Leasing ("Progressive") and Aaron's Business ("AB") segments were in violation of the Federal Trade Commission ("FTC") Act and/or relevant FTC regulations; (iii) consequently, Aaron's earnings from those segments were partially derived from unlawful business practices and were thus unsustainable; (iv) the full extent of Aaron's liability regarding the FTC's investigation into its Progressive and AB segments, Aaron's noncompliance with the FTC Act, and the likely negative consequences of all the foregoing on the Company's financial results; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.
Story continues
To learn more contact Vincent Wong, Esq. either via email
or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail:
SOURCE:
The Law Offices of Vincent Wong
View source version on accesswire.com:
https://www.accesswire.com/579005/SHAREHOLDER-ALERT-PTLA-GERN-AAN-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines
View comments
Is ASM International NV’s (AMS:ASM) 21% Better Than Average?2024-09-29 11:04
In packed churches and secret masses, papal visit brings Gulf Catholics hope2024-09-29 10:42
Get Disruptive in 2019 With These 10 ETFs2024-09-29 10:41
GBP/USD Price Forecast – British Pound Charging Into Big Figure Again2024-09-29 10:32
Jet Airways defaults on debt payment to banks, shares drop2024-09-29 10:24
Don't Fall for This Common January Mistake2024-09-29 10:21
Commodities Daily Forecast – February 1, 20192024-09-29 10:04
eXp World Holdings Appoints Fee Gentry to Board of Directors2024-09-29 09:52
7 of Hillary Clinton’s Biggest Flip-Flops2024-09-29 09:47
How Are PlayStation 5, Xbox Poised Before Launch?2024-09-29 12:22
China to execute driver who killed passenger of ride-hailing firm Didi2024-09-29 12:11
People in the News—Jan. 2, 2019—Arnold & Porter2024-09-29 11:19
BRIEF-Zhejiang Jiahua Energy Chemical Says Is Warned By Regulator For Violation Of Information Disclosure2024-09-29 11:18
Should Value Investors Consider Dycom (DY) Stock Now?2024-09-29 11:02
Should We Be Delighted With Techedge S.p.A.’s (BIT:EDGE) ROE Of 18%?2024-09-29 10:50
Cathay Pacific Honors $16,000 First-Class Fares Sold for $6752024-09-29 10:26
Have Insiders Been Selling Parker-Hannifin Corporation (NYSE:PH) Shares?2024-09-29 09:50
Tristan Thompson Reveals The Importance Of Patience In Today's World2024-09-29 09:45
Do You Like Guardian Capital Group Limited (TSE:GCG.A) At This P/E Ratio?2024-09-29 09:41